Stock NAVB NAVIDEA BIOPHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

MarketScreener Editorial Features Navidea Biopharmaceuticals, Inc.

Equities

NAVB

US63937X2027

Delayed OTC Markets
Other stock markets
 01:20:58 2024-05-08 pm EDT 		5-day change 1st Jan Change
0.0392 USD -2.00% Intraday chart for Navidea Biopharmaceuticals, Inc. +12.00% -28.99%
2023 Navidea Biopharmaceuticals, Inc. announced that it expects to receive $0.75 million in funding CI
2023 Navidea Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

MarketScreener Editorial Features

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NAVB Stock
  4. News Navidea Biopharmaceuticals, Inc.
  5. MarketScreener Editorial Features
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW